Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
SOURCE Decision Resources Group
A Challenging Intellectual Property Landscape Signals the Necessity of a New Approach, According to Findings from Decision Resources Group
BURLINGTON, Mass., April 30, 2014 /PRNewswire/ -- Decision Resources Group finds that certain multinational pharmaceutical companies (MNCs) are experimenting with new market access and pricing strategies to ensure continued access to India's large patient populations and expanding market. The Indian government wants drugs to be reasonably affordable for all, not just those wealthy patients who can afford them. This bar is going to be very difficult to meet because of the severe poverty in much of the country and India's low gross national income per capita.
Other key findings from the India Market Access Tracker advisory service:
Comments from Decision Resources Group Analyst Lulu Pickering, Ph.D.:
* The World Trade Organization's Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement.
About Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. Clients rely on this analysis and data to make informed decisions. Find out more at www.DecisionResourcesGroup.com.
All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.
For more information, contact:
Decision Resources Group
©2012 PR Newswire. All Rights Reserved.